Latest Schedule 13G passive stakes

AWM Investment Company, Inc. has filed a Schedule 13G, reporting no beneficial ownership of Gaia, Inc. Class A Common Stock as of June 30, 2026.

AWM Investment Company, Inc. has filed a Schedule 13G amendment, reporting zero beneficial ownership of MDxHealth SA common stock as of June 30, 2026.

Kornitzer Capital Management, Inc. has filed a Schedule 13G, reporting beneficial ownership of 6.3% of Landmark Bancorp Inc.'s common stock as of June 30, 2026.

Tego Cyber Inc. has reported beneficial ownership of 2,373,134 shares, representing 10.4% of the outstanding common stock of Intrusion Inc.

Tego Cyber Inc. has reported beneficial ownership of 2,373,134 shares, representing 10.4% of the outstanding common stock of Intrusion Inc.

Knoll Capital Management, LLC, along with Fred Knoll and Gakasa Holdings, LLC, has reported beneficial ownership of 1,211,957 shares, representing 5.3% of Elicio Therapeutics, Inc.'s common stock.

Base Partners Consultoria de Investimentos E Negocios Ltda. and Fernando Spnola report beneficial ownership of 7,967,893 shares of Netskope Inc. Class A Common Stock, representing 3.2% of the class.

Several BNY Mellon entities have collectively reported beneficial ownership of approximately 13.8% of Black Rock Coffee Bar, Inc. common stock as of June 30, 2026.

Several BNY Mellon entities have collectively reported beneficial ownership of approximately 13.8% of Black Rock Coffee Bar, Inc. common stock as of June 30, 2026.

State Street Corporation and its affiliate SSGA Funds Management, Inc. have reported beneficial ownership of 10.4% and 7.4% respectively of Astronix Corp's common stock as of June 30, 2026.

State Street Corporation and its affiliate SSGA Funds Management, Inc. have reported beneficial ownership of 10.4% and 7.4% respectively of Astronix Corp's common stock as of June 30, 2026.

Wellington Management Group LLP and its affiliates have reported beneficial ownership of 10.4% of US Foods Holding Corp. common stock as of June 30, 2026.

Wellington Management Group LLP and its affiliates have reported a significant beneficial ownership stake of 10.5% in MBX Biosciences, as of June 30, 2026.

Wellington Management Group LLP and its affiliates have reported beneficial ownership of 10.5% of Excelerate Energy, Inc. common stock as of June 30, 2026.

Wellington Management Group LLP and its affiliates have reported beneficial ownership of 0.9% of Apogee Therapeutics, Inc. common stock as of June 30, 2026.

BlackRock Portfolio Management LLC has reported a beneficial ownership of 11.8% in FrontView REIT, Inc. as of June 30, 2026.

BlackRock Portfolio Management LLC has reported a beneficial ownership of 10.4% in Chatham Lodging Trust's common stock as of June 30, 2026.

BlackRock Portfolio Management LLC reports beneficial ownership of 200,000 shares, representing 34.5% of the outstanding common stock in the iShares Bitcoin Premium Income ETF.

T. Rowe Price Investment Management, Inc. has reported beneficial ownership of 10.4% of Chesapeake Utilities Corp. common stock as of June 30, 2026.

T. Rowe Price Investment Management, Inc. has filed a Schedule 13G, reporting beneficial ownership of 7,790,567 shares, representing 5.7% of the outstanding common stock of Lattice Semiconductor Corp.

T. Rowe Price Investment Management, Inc. has reported a beneficial ownership of 10.2% in CenterPoint Energy Inc. as of June 30, 2026.

T. Rowe Price Investment Management, Inc. has reported beneficial ownership of 12.0% of Anterix Inc.'s common stock as of June 30, 2026.

T. Rowe Price Investment Management, Inc. has reported beneficial ownership of 7.0% of Black Diamond Therapeutics' common stock as of June 30, 2026.

T. Rowe Price Investment Management, Inc. has reported beneficial ownership of 16,178,963 shares, representing 10.2% of the outstanding common stock of Denali Therapeutics Inc.

T. Rowe Price Investment Management, Inc. has filed a Schedule 13G, reporting beneficial ownership of 772,969 shares, representing 1.3% of the outstanding common stock of Apogee Therapeutics Inc.

T. Rowe Price Investment Management, Inc. has filed a Schedule 13G, reporting beneficial ownership of 753,680 shares, representing 5.8% of TWFG Inc.'s common stock as of June 30, 2026.

T. Rowe Price Investment Management, Inc. has reported a significant beneficial ownership stake of 11.4% in Waterbridge Infrastructure-CL A, holding 5,375,063 shares.

T. Rowe Price Associates, Inc. has filed a Schedule 13G, reporting beneficial ownership of 10.1% of InterDigital Inc.'s common stock as of June 30, 2026.

T. Rowe Price Associates, Inc. has reported a 5.4% ownership stake in Fabrinet as of June 30, 2026.

T. Rowe Price Associates, Inc. has reported beneficial ownership of 10.5% of Monte Rosa Therapeutics Inc.'s common stock as of June 30, 2026.